LewisBarrySilvermanMD
Pediatric Hematology & Oncology • Boston, MAVice Chair, Clinical Affairs, Dept. of Pediatric Oncology, Dana-Farber Cancer Institute; Associate Chief, Pediatric Oncology, Boston Children's Hospital; Professor of Pediatrics, Harvard Medical School
Dr. Silverman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-6191- Is this information wrong?
Education & Training
Children's Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1994 - 1997- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1991 - 1994
Harvard Medical SchoolClass of 1991
Certifications & Licensure
ME State Medical License 2022 - 2026
MA State Medical License 1994 - 2025
CT State Medical License 2022 - 2025
RI State Medical License 2022 - 2024- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2000 Sep 01
- Treatment of Acute Lymphoblastic Leukemia in Children Start of enrollment: 2005 Apr 01
- Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsTreatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI ...Valtis, Y., Flamand, Y., Shimony, S., Place, A., Silverman, L., Vrooman, L., Brunner, A., Sallan, S., Wadleigh, M., Stone, R., DeAngelo, D., Luskin, M.> ;Leukemia. 2024 Mar 1
- Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.Jennifer J G Welch, Yael Flamand, Kristen E Stevenson, Donna S Neuberg, Uma H Athale, Kara M Kelly, Caroline Laverdiere, Bruno Michon, Andrew E Place, Stephen E Sallan...> ;Pediatric Blood & Cancer. 2023 Nov 1
- 2 citationsEffect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Richard M Stone, Martha Wadleigh, ...> ;Blood Advances. 2023 Sep 26
- Join now to see all
Abstracts/Posters
- Single Cell RNA-Seq Reveals Deranged Developmental Hierarchy with Coexisting Oncogenic States and Immune Evasion Programs in ETP T-ALLLewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Genetic Ancestry and Skeletal Toxicities Among Childhood Acute Lymphoblastic Leukemia Patients in the DFCI 05-001 CohortLewis B. Silverman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- New Data and Paradigms in ALL: Insights and Applications61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Grant Support
- Treatment Of Childhood And Adult AllNational Cancer Institute2006–2010
- Pharmacogenetics Of Asparaginase-Induced PancreatitisEunice Kennedy Shriver National Institute Of Child Health &Human Development2003–2007
Professional Memberships
- Member
- Member
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Boston Children's HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
